You Position: Home > Paper
Successive treatment for patients with chronic hepatitis B who failed in "rescue therapy"
( views:248, downloads:56 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF CLINICAL INFECTIOUS DISEASES
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1674-2397.2009.04.015
- Key Word:
- 肝炎;乙型;慢性;拉米夫定耐药;阿德福韦酯;Chronic hepatitis B;Lamivudine resistance;Adefovir dipivoxil
Abstract： @@ 在慢型乙型肝炎(CHB)抗病毒治疗过程中,当患者产生对拉米夫定(LAM)耐药,并同时出现肝炎再活动,首选的治疗方法是加用阿德福韦酯(ADV),通常肝炎活动可以再次得到控制,这种方法被称为"挽救性治疗"[1].然而,少数患者在接受挽救性治疗后疗效仍然不佳,给抗病毒治疗带来了巨大挑战.笔者对这部分患者的后续治疗进行了研究和分析.
- [1]赵鸿,斯崇文,张跃新,等.国产阿德福韦酯片治疗HBeAg阳性慢性乙型肝炎的双盲、随机、多中心临床研究[J].2007,(2).
- [2]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].2005,(6).
- [3]Brillet R,Hezode C,Dhumeaux D,etc.Efficacy and safety of adefovir dipivoxil 20mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10mg daily.[J].2007,46(5).
- [4]Saveriadis A,Manolakopoulos S,Koutsounas S,etc.Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.[J].2008,27(3).
- [5]Olivero A,Alessandria C,Barbon V,etc.Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine.[J].2008,48(4).